$13.1 million grant backs bacterial therapies for resistant breast cancer
A scientist at Weill Cornell Medicine is working with colleagues at the University of Massachusetts Amherst on new, complementary research efforts engineering therapeutic Salmonella to target critical gaps in treatment for drug-resistant triple-negative breast cancers.
Read original article on The Medical News →Related news
-
Nearly one-third of new nurse practitioners trained at for-profit schools
United Kingdom
-
What went right this week: the good news that matters
United Kingdom
-
Positive parenting in early childhood linked to stronger brain reward responses
United Kingdom
-
Your favorite music could help reduce the pain of small medical procedures
United Kingdom
-
SPRED2 coordinates three signaling pathways to suppress liver cancer stemness
United Kingdom
-
Certain gut bacteria may intensify inflammatory responses to vaccines
United Kingdom
-
DNA Typewriter tracks cell divisions and developmental decisions in mice
United Kingdom
-
Rare dendritic cells may promote immune tolerance in metastatic cancer
United Kingdom